By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

DiObex, Inc. 

600 Townsend Street, Suite 271

San Francisco  California  94103  U.S.A.
Phone: 415-551-0400 Fax: 415-551-4113


SEARCH JOBS


Industry
Biotechnology






Company News
Drug Company DiObex, Inc. Shutting Down 4/8/2009 8:26:34 AM
DiObex, Inc. to Present at 2008 Biotechnology Industry Organization (BIO) International Convention 6/12/2008 10:18:33 AM
DiObex, Inc. to Present at Canaccord Adams Diabetes and Obesity Conference 6/4/2008 12:21:33 PM
DiObex, Inc. Announces Presentation of Scientific Poster at Annual Meeting of American Society for Clinical Pharmacology and Therapeutics 4/1/2008 7:13:26 AM
DiObex, Inc. and Camurus Sign License Agreement for the Development of DIO-901 in FluidCrystal(R) Extended Release 3/18/2008 7:10:38 AM
DiObex, Inc. Awarded Patent for the Prevention of Insulin-Induced Hypoglycemia Patent Protects Very Low Dose Glucagon 1/8/2008 7:35:04 AM
DiObex, Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 10/25/2007 10:05:06 AM
DiObex, Inc. to Present at Biotechnology Industry Organization (BIO) Investor Forum 2007 10/2/2007 10:28:18 AM
DiObex, Inc. Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug 9/26/2007 7:32:30 AM
DiObex, Inc. to Present at Biotechnology Industry Organization (BIO) Mid-America Venture Forum 9/18/2007 8:12:40 AM
12
//-->